Dopamine Related Published Studies
Well-designed clinical trials related to Dopamine
Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia. [2008.08]
Induction of tolerance of dopaminergic responses in man. [2008.08]
Brain dopamine response in human opioid addiction. [2008.07]
Effects of an attachment-based intervention on daily cortisol moderated by dopamine receptor D4: a randomized control trial on 1- to 3-year-olds screened for externalizing behavior. [2008.06]
A population pharmacokinetic model of epidural lidocaine in geriatric patients: effects of low-dose dopamine. [2008.06]
The role of dopamine in alcohol self-administration in humans: individual differences. [2008.06]
Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. [2008.06]
Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans. [2008.06]
Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study. [2008.05]
The effects of acute dopamine reuptake inhibition on performance. [2008.05]
Dopamine depletion impairs frontostriatal functional connectivity during a set-shifting task. [2008.04.02]
Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies. [2008.04]
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. [2008.04]
Where dopamine meets opioids: a meta-analysis of the placebo effect in RLS treatment studies. [2008.02.14]
Levodopa increases memory encoding and dopamine release in the striatum in the elderly. [2008.02]
Taq1A polymorphism in the dopamine D2 receptor gene predicts brain metabolic response to aripiprazole in healthy male volunteers. [2008.02]
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness. [2008.02]
Dopaminergic Potentiation of rTMS-Induced Motor Cortex Inhibition. [2008.01.15]
Experimental evidence for differential susceptibility: dopamine D4 receptor polymorphism (DRD4 VNTR) moderates intervention effects on toddlers' externalizing behavior in a randomized controlled trial. [2008.01]
A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure. [2008.01]
Dopamine D2 receptor occupancy levels of acute sulpiride challenges that produce working memory and learning impairments in healthy volunteers. [2008.01]
Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli. [2008.01]
The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study. [2008.01]
Pupillography as a sensitive, noninvasive biomarker in healthy volunteers: first-in-man study of BAY 63-9044, a new 5-HT1A-receptor agonist with dopamine agonistic properties. [2007.12]
Where dopamine meets opioids: a meta-analysis of the placebo effect in RLS treatment studies. [2007.10.11]
The efficacy of the dopamine D2/D3 antagonist tiapride in maintaining abstinence: a randomized, double-blind, placebo-controlled trial in 299 alcohol-dependent patients. [2007.10]
The role of dopamine in attentional and memory biases for emotional information. [2007.10]
Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. [2007.10]
Dopaminergic modulation of timing control and variability in the gait of Parkinson's disease. [2007.09.15]
Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial. [2007.09]
Effects of acepromazine on the cardiovascular actions of dopamine in anesthetized dogs. [2007.09]
Use of ephedrine and dopamine in dogs for the management of hypotension in routine clinical cases under isoflurane anesthesia. [2007.09]
Effects of dopamine on retinal and choroidal blood flow parameters in humans. [2007.09]
Dopamine versus dobutamine in very low birthweight infants: endocrine effects. [2007.09]
Effects of intravenous glucose on dopaminergic function in the human brain in vivo. [2007.09]
Serotonergic response to stress: a protective factor against abnormal dopaminergic reactivity in schizophrenia? [2007.09]
A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia. [2007.08]
Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. [2007.08]
Sulpiride and melatonin decrease tinnitus perception modulating the auditolimbic dopaminergic pathway. [2007.08]
Fenoldopam vs dopamine as a nephroprotective strategy during living donor kidney transplantation: preliminary data. [2007.07]
A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. [2007.07]
Dopaminergic influences on changes in human tactile acuity induced by tactile coactivation. [2007.07]
Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia. [2007.06]
Implicit learning of sequential bias in a guessing task: failure to demonstrate effects of dopamine administration and paranormal belief. [2007.06]
Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR. [2007.05]
Dopaminergic toxicity of the herbicide atrazine in rat striatal slices. [2007.03.22]
Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion. [2007.03]
Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol. [2007.02]
Effects of the dopamine agonist piribedil on prefrontal temporal cortical network function in normal aging as assessed by verbal fluency. [2007.01.30]
Evidence for a dopaminergic link between working memory and agentic extraversion: an analysis of load-related changes in EEG alpha 1 activity. [2007.01]
The efficacy of the dopamine D2/D3 antagonist tiapride in maintaining abstinence: a randomized, double-blind, placebo-controlled trial in 299 alcohol-dependent patients. [2006.11.01]
Tonic dopaminergic stimulation impairs associative learning in healthy subjects. [2006.11]
C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. [2006.11]
A shift of paradigm: from noradrenergic to dopaminergic modulation of learning? [2006.10.25]
A comparison of fenoldopam with dopamine and sodium nitroprusside in patients undergoing cross-clamping of the abdominal aorta. [2006.10]
Brain dopamine and kinematics of graphomotor functions. [2006.10]
Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. [2006.09.25]
Dopaminergic modulation of semantic priming in healthy volunteers. [2006.09.15]
Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. [2006.09]
Dopamine transporter genotype influences the physiological response to medication in ADHD. [2006.08]
Is dopamine behind the health benefits of red wine? [2006.08]
Investigating the dopaminergic basis of extraversion in humans: A multilevel approach. [2006.07]
Sensorimotor effects of pergolide, a dopamine agonist, in healthy subjects: a lateralized readiness potential study. [2006.07]
Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood. [2006.07]
Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes. [2006.06]
'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. [2006.05]
Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. [2006.05]
Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock. [2006.04]
Betamethasone does not prevent nausea and vomiting induced by the dopamine-agonist apomorphine. [2006.04]
PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. [2006.03]
A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. [2006.03]
Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials. [2006.01]
Pharmacogenetics and obesity: common gene variants influence weight loss response of the norepinephrine/dopamine transporter inhibitor GW320659 in obese subjects. [2005.12]
Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study. [2005.10.01]
Cortisol decreases and serotonin and dopamine increase following massage therapy. [2005.10]
The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values. [2005.10]
Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans. [2005.10]
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. [2005.09]
Dopaminergic effects on encoding of a motor memory in chronic stroke. [2005.08.09]
The effects of acute tyrosine and phenylalanine depletion on spatial working memory and planning in healthy volunteers are predicted by changes in striatal dopamine levels. [2005.08]
A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. [2005.08]
A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory. [2005.08]
Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis. [2005.07]
Renal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition? [2005.07]
Dopaminergic influences on formation of a motor memory. [2005.07]
Dopamine transporter genotype and methylphenidate dose response in children with ADHD. [2005.07]
End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: a pharmacokinetic/pharmacodynamic, randomized, double-blind study. [2005.07]
Physiologic impact of low-dose dopamine on renal function in the early post renal transplant period. [2005.06.15]
Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation. [2005.06]
Differential dopaminergic modulation of executive control in healthy subjects. [2005.04]
Effect of saline load and metoclopramide on the renal dopaminergic system in patients with heart failure and healthy controls. [2005.03]
Dopamine transporter gene associated with diminished subjective response to amphetamine. [2005.03]
Effects of dopamine and norepinephrine on systemic and hepatosplanchnic hemodynamics, oxygen exchange, and energy balance in vasoplegic septic patients. [2005.01]
Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to L-dopa therapy. [2005.01]
Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol. [2005.01]
Effects of chai hu (radix burpleuri) containing formulation on plasma beta-endorphin, epinephrine and dopamine on patients. [2005]
Treatment with medications affecting dopaminergic and serotonergic mechanisms: effects on fluency and anxiety in persons who stutter. [2005]
Use of dopamine agonist pergolide in outpatient treatment of cocaine dependence. [2005]
Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR. [2005]
Well-designed clinical trials possibly related to Dopamine
Thorough QT/QTc study in patients with advanced parkinson's disease: cardiac safety of rotigotine. [2008.11]
A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. [2008.10]
|
